Drawing for COAVE THERAPEUTICS

USPTO serial 97197299

COAVE THERAPEUTICS

Reviewed by CopyMark Law Group

Reg. 6999420Status 700Registered
Filing date
Status date
Registration date
Mar 14, 2023
Examiner
BRACEY, KAREN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with COAVE THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Pina Campagna

Pina Campagna CARTER, DELUCA AND FARRELL LLP576 BROAD HOLLOW RD.MELVILLE, NY 11747UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations in the nature of viral systems, gene therapy systems, and nucleic acid delivery systems comprised of viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells used to deliver modified genetic material into other cells for medical purposes for the diagnosis, treatment or prevention of ophthalmological disorders, diseases of the central and peripheral nervous system, hereditary disorders, genetic disorders and disorders of monogenic origin; Pharmaceutical preparations and products in the nature of genetically modified cells for use in gene therapy for medical purposes; Pharmaceutical preparations, namely, vaccines, prophylactic pharmaceuticals in the nature of antigens, and other genetically modified pharmaceuticals cells or tissue for use in nucleic acid therapy, gene therapy and cell therapy; Drug delivery agents in the nature genetically modified compounds for medical, pharmaceutical or veterinary purposes; Biological tissue cultures for medical purposes; Chemical or biological reagents for medical, pharmaceutical or veterinary purposes, namely, for nucleic acid therapy, gene therapy and cell therapy; Biological preparations for medical, pharmaceutical or veterinary purposes, namely, for use in connection with medical and clinical gene therapy, nucleic acid therapy and cell therapy to diagnose, treat and prevent ophthalmological disorders, diseases of the central and peripheral nervous system, hereditary disorders, genetic disorders and disorders of monogenic originACTIVE—
042Product research and development in the fields of biotechnology, biology, biomedicine, pharmacy, medical sciences, gene therapy, chemistry and biochemistry; Biological, biomedical and pharmaceutical therapeutic research services; Research in the fields of pharmaceutical and biological therapeutic preparations, namely, gene therapy and nucleic acid delivery systems for use in clinical trials and post-marketing trials; Pharmaceutical research and development; Provision of scientific research information in the fields of pharmaceuticals, biomedicine, gene therapy, clinical trials and post-marketing trials; Biological research; Chemical analysis and research services; Providing medical and scientific research information in the field of clinical trials; conducting clinical trials for others; Medical research servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 14, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Mar 14, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 27, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 27, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 7, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 22, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 21, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 21, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 21, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 4, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 4, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 4, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 4, 2022DOCKASSIGNED TO EXAMINER—
Jan 5, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 3, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance